3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.

3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.

Verotoxin-producing Escherichia coli(VTEC) belonging to several different O serotypes, has been associated with watery or bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. One serotype (O157: H7) is now recognized as an important human pathogen of public health concern. Till now, little information was available on the global prevalence of VTEC of O157 and other serotypes in patients with diarrhea and HUS in Iraq.This book provides a unique data on the prevalence and characterization of VTEC obtained from patients with diarrhea

India initiated macroeconomic stabilization measures and structural reforms in July 1991 and since then the reform process has been refined and elaborated. The economic growth in India during the reform period has been generally regarded as "good" but not "sufficiently inclusive." These concerns necessitate a detailed stock taking of India's economic policies and its outcome over the reform period to identify its success and failures and suggest for restructuring the economic policies to achieve a higher, sustainable and sufficiently inclusive growth rate in future. This edited book examines the impact of the economic reforms on various fronts since 1991. It contains thirty seven articles divided into five sections viz.; section I: growth, poverty, unemployment and reforms; section II: economic reforms and Indian agriculture; section III: sectoral and regional issues; section IV: banking and financial sector reforms; and section V: India's external sector reforms. The book is useful for the students of various disciplines who have interest in the subject and are involved in the research and development.

The use of plants for biological, pesticidal as well as medicinal purposes has long history. In material-resource poor countries like Tanzania where medical and veterinary facilities cannot satisfy national demands, plants have played a big role in combating both human and animal diseases. In addition, since the use of synthetic pesticides in the control of pests is almost incompatible and uneconomical, traditional practices incorporate the use of plants as pesticides. Indigenous knowledge (IK) however has remained unexploited with limited research and resources committed. The book describes the findings of the research carried out in an attempt to have detailed account of biological, pesticidal and medicinal potentials of Tanzanian indigenous plants. This is just to ensure that users have an understanding of the different biological (antimicrobial, antioxidant, etc) and pesticidal activities of the plants they use in a way to guarantee safety for them and their livestock as well as for further industrial endavours in the country.

Increasing interdependence and rapidly changing relationships among nations have given rise to growing concerns about health problems worldwide. Medical education is central to the future provision of health services in the emerging world order. This major reference work presents the history, evolution, current status, and future direction of medical education in 28 countries around the world, and describes current issues and trends in each. The countries profiled represent a broad range of political, economic, and social conditions. Following introductory overviews and discussions of global issues in medical education and evaluation, each chapter describes the health care delivery system; role of national policy; undergraduate, graduate, and continuing medical education; licensure and certification; and international linkages in a particular country. Each chapter includes detailed statistical information and extensive references to additional resources about each country. The volume also includes comprehensive information about relevant national and international organizations, institutions, and govenment agencies that influence medical education policy determination and implementation; it provides basic biblographic source material for all major topics and for each country.